Press release
Wet Age-Related Macular Degeneration (Wet-AMD) Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Outlook Therapeutics, Opthea, Sylentis, Boehringer Ingelhe
Wet Age-Related Macular Degeneration (Wet-AMD) Clinical Trials
DelveInsight's analysis indicates that the Wet Age-Related Macular Degeneration (Wet-AMD) pipeline involves over 60 key companies actively developing more than 70 therapies for Wet-AMD treatment.
Wet Age-Related Macular Degeneration (Wet-AMD) Overview:
Wet Age-related Macular Degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp, detailed vision. It is the more aggressive form of AMD compared to the dry type and can progress rapidly, potentially causing significant vision loss if untreated. This form occurs when abnormal blood vessels grow beneath the macula, leaking blood or fluid that disrupts retinal function and leads to scarring. Wet AMD primarily affects individuals over 50 and is a leading cause of central vision impairment in older adults.
Early symptoms often include blurry or distorted central vision, making tasks like reading, recognizing faces, or performing fine work difficult. Straight lines may appear bent or wavy, a condition called metamorphopsia, and dark or blank spots (scotomas) can appear in the central field of vision. Symptoms often arise suddenly and may worsen quickly, although peripheral vision typically remains unaffected.
Wet AMD develops due to abnormal growth of blood vessels (angiogenesis) beneath the retina, often driven by excessive production of vascular endothelial growth factor (VEGF). While the exact cause is not fully understood, risk factors include age, family history, smoking, obesity, hypertension, and a diet low in antioxidants. Environmental factors, such as prolonged exposure to ultraviolet (UV) light, may also contribute to retinal damage.
Diagnosis involves a comprehensive eye exam, including visual acuity testing and retinal examination after pupil dilation. Optical coherence tomography (OCT) is frequently used to capture high-resolution, cross-sectional images of the retina to detect fluid buildup or swelling. Fluorescein angiography may also be employed, where a dye is injected into the bloodstream to highlight abnormal retinal blood vessels.
Request for a detailed insights report on Wet Age-Related Macular Degeneration (Wet-AMD) pipeline insights [https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
"Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Wet Age-Related Macular Degeneration (Wet-AMD) Therapeutics Market.
Key Takeaways from the Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Report
DelveInsight's Wet Age-Related Macular Degeneration (Wet-AMD) pipeline report highlights a vibrant landscape, with over 60 active companies developing more than 70 therapies for Wet-AMD treatment.
Key companies in this space include Outlook Therapeutics, Opthea, Sylentis, Boehringer Ingelheim, Molecular Partners, Sam Chun Dang Pharm, Generium, Alvotech, Adverum Biotechnologies, EyePoint Pharmaceuticals, 4D Molecular Therapeutics, OliX Pharmaceuticals, Kyowa Kirin, Exonate, and others, all actively evaluating new drugs to improve treatment outcomes for Wet-AMD.
Prominent pipeline candidates under development include ONS-5010, OPT-302, SYL1801, BI 836880, and others.
Recent updates include:
*
March 2025: Teva Pharmaceutical Industries and Alvotech announced that the FDA will review their biosimilar candidate, AVT06, positioned as a potential alternative to Regeneron's Eylea (aflibercept). The introduction of biosimilars like AVT06 could expand treatment options and potentially lower costs for patients.
*
ABBV-RGX-314, developed by Regenxbio in collaboration with AbbVie, is an investigational gene therapy aimed at providing a potential one-time treatment for Wet-AMD and other retinal conditions. It is currently in Phase II clinical trials, exploring both subretinal and suprachoroidal delivery methods.
Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Wet Age-Related Macular Degeneration (Wet-AMD) Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Wet Age-Related Macular Degeneration (Wet-AMD) treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Wet Age-Related Macular Degeneration (Wet-AMD) market.
Download our free sample page report on Wet Age-Related Macular Degeneration (Wet-AMD) pipeline insights [https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Wet Age-Related Macular Degeneration (Wet-AMD) Emerging Drugs
*
ONS-5010: Outlook Therapeutics
*
OPT-302: Opthea
*
SYL1801: Sylentis
*
BI 836880: Boehringer Ingelheim
Wet Age-Related Macular Degeneration (Wet-AMD) Companies
More than 60 leading companies are actively developing therapies for Wet Age-Related Macular Degeneration (Wet-AMD), with Outlook Therapeutics advancing a drug candidate to the Phase III stage, the most advanced in development.
DelveInsight's report covers around 70+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Wet Age-Related Macular Degeneration (Wet-AMD) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Wet Age-Related Macular Degeneration (Wet-AMD) Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Wet Age-Related Macular Degeneration (Wet-AMD) Therapies and Key Companies: Wet Age-Related Macular Degeneration (Wet-AMD) Clinical Trials and advancements [https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Therapeutic Assessment
- Wet Age-Related Macular Degeneration (Wet-AMD) Assessment by Product Type
- Wet Age-Related Macular Degeneration (Wet-AMD) By Stage
- Wet Age-Related Macular Degeneration (Wet-AMD) Assessment by Route of Administration
- Wet Age-Related Macular Degeneration (Wet-AMD) Assessment by Molecule Type
Download Wet Age-Related Macular Degeneration (Wet-AMD) Sample report to know in detail about the Wet Age-Related Macular Degeneration (Wet-AMD) treatment market @ Wet Age-Related Macular Degeneration (Wet-AMD) Therapeutic Assessment [https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Wet Age-Related Macular Degeneration (Wet-AMD) Current Treatment Patterns
4. Wet Age-Related Macular Degeneration (Wet-AMD) - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Wet Age-Related Macular Degeneration (Wet-AMD) Late-Stage Products (Phase-III)
7. Wet Age-Related Macular Degeneration (Wet-AMD) Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Wet Age-Related Macular Degeneration (Wet-AMD) Discontinued Products
13. Wet Age-Related Macular Degeneration (Wet-AMD) Product Profiles
14. Wet Age-Related Macular Degeneration (Wet-AMD) Key Companies
15. Wet Age-Related Macular Degeneration (Wet-AMD) Key Products
16. Dormant and Discontinued Products
17. Wet Age-Related Macular Degeneration (Wet-AMD) Unmet Needs
18. Wet Age-Related Macular Degeneration (Wet-AMD) Future Perspectives
19. Wet Age-Related Macular Degeneration (Wet-AMD) Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Reports Offerings [https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=wet-agerelated-macular-degeneration-wetamd-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-outlook-therapeutics-opthea-sylentis-boehringer-ingelhe]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wet Age-Related Macular Degeneration (Wet-AMD) Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Outlook Therapeutics, Opthea, Sylentis, Boehringer Ingelhe here
News-ID: 4161227 • Views: …
More Releases from ABNewswire
Phenix City Medical Practice Announces Expanded Healthcare Services, Addressing …
Preferred Medical Group, Phenix City, announces the expansion of its healthcare services and improved patient access, addressing community demand for comprehensive medical care with integrated pediatric, adult, and therapeutic services under one roof.
Preferred Medical Group, Phenix City [https://preferredmedgroup.com/], has announced significant enhancements to its healthcare services, responding to increased community demand for accessible and comprehensive medical care. The medical practice, located at 3700 South Railroad Street, has introduced streamlined patient…
Auburn Medical Practice Expands Integrated Care Model as Primary Care Doctor Add …
Preferred Medical Group - Auburn expands ADHD services and integrated care model, offering comprehensive family medicine, behavioral health, and specialized attention disorder treatment in one convenient East Alabama location.
Preferred Medical Group - Auburn [https://preferredmedgroup.com/] has announced significant enhancements to its integrated healthcare services, responding to increased demand for ADHD treatment and comprehensive family medical care in East Alabama. The Auburn location, situated at 318 Samford Village Court, Suite 100, now…
Local ADHD Doctor Program Launches at Preferred Medical Group - Opelika for East …
Preferred Medical Group - Opelika launches an integrated ADHD treatment program that combines pediatric care, psychiatry, and therapy services to address regional healthcare needs for East Alabama families.
Opelika healthcare providers have taken a significant step toward addressing the growing need for specialized attention deficit hyperactivity disorder services in East Alabama. Preferred Medical Group - Opelika [https://preferredmedgroup.com/] has announced the expansion of comprehensive ADHD treatment programs, integrating pediatric care with behavioral…
Prominent Criminal Lawyer in Galveston Firm Celebrates 25+ Years of Texas Gulf C …
Tad Nelson & Associates celebrates over 25 years of criminal defense excellence across the Texas Gulf Coast, combining local roots, community involvement, and personalized legal services that span multiple counties.
A prominent Texas law firm has reached a significant milestone, celebrating over 25 years of providing criminal defense and family law services across the Greater Houston area and Galveston County. The achievement underscores the firm's steadfast commitment to serving Texas communities…
More Releases for Wet
Wet Age-Related Macular Degeneration (Wet AMD) market is expected to reach USD 1 …
Wet age-related macular degeneration (Wet AMD) is a chronic, progressive eye disorder and one of the leading causes of severe vision loss in people over 60. Unlike the dry form of AMD, Wet AMD is characterized by the growth of abnormal blood vessels under the retina that leak fluid or blood, leading to rapid central vision loss. While Wet AMD accounts for only about 10-15% of all AMD cases, it…
Wet And Cold Appliance Market Size Analysis by Application, Type, and Region: Fo …
USA, New Jersey- According to Market Research Intellect, the global Wet And Cold Appliance market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The wet and cold appliance market is expanding steadily, driven by changing consumer lifestyles, increasing urbanization, and rising demand for home automation. Appliances…
Semiconductor Electronic Wet Chemicals Market
Semiconductor Electronic Wet Chemicals Market Overview
Electronic wet chemicals are ultra-pure nature due to which they are extensively used in cleaning and etching application during semiconductor production and processing.
This report provides a deep insight into the global Semiconductor Electronic Wet Chemicals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market…
Wet and Dry Vacuum Cleaner Market
The "Wet and Dry Vacuum Cleaner Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Wet and Dry Vacuum Cleaner Market, 2024-2031
Verified Market Research's most recent report, "Wet and Dry Vacuum Cleaner Market: Global Industry Trends, Share, Size,…
Wet Filtered Downdraught Workbench Market
Wet filtered downdraught workbench is the industry's leading solution for the collection of combustible metal dust which can safely removes combustible materials while complying with NFPA and OSHA combustible dust guidelines.
The global Wet Filtered Downdraught Workbench market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine…
Corn Wet-milling Market Corn Wet Milling Market Share, Size, Demand, Key Players …
Market Analysis and Insights of Global Corn Wet-milling Market
The corn wet-milling market is expected to witness market growth at a rate of 5.70% in the forecast period of 2022 to 2029. Data Bridge Market Research report on corn wet-milling market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The growth in awareness globally is…
